Topics › Drug Policy › Ibogaine
Commentary by Leonard Gilroy
Psychedelics Policy Newsletter by Gregory Ferenstein
Commentary by Gregory Ferenstein
Testimony by Madison Carlino
Testimony by Geoffrey Lawrence, Leonard Gilroy and Gregory Ferenstein
Commentary by Layal Bou Harfouch